IQVIA Holdings sees growth across divisions and beats analysts’ estimates
- IQVIA Holdings reports higher fourth-quarter sales and profit
- Adjusted earnings were $2.84 a share, beating analysts’ expectations
- Revenue rose more than 3% to $3.87 billion, surpassing analysts’ estimates
- Technology & Analytics Solutions unit sales increased by over 2%
- R&D division sales grew by nearly 5%
- Contract Sales & Medical Solutions business revenue increased by 2%
- IQVIA targets revenue of $15.4 billion to $15.65 billion for 2024
- Revenue guidance includes a $300 million impact from Covid-related sales
IQVIA Holdings, a provider of analytics and services to the life-sciences industry, has reported higher sales and profit in the fourth quarter. The company’s adjusted earnings of $2.84 per share surpassed analysts’ expectations of $2.82 per share. Revenue also exceeded estimates, rising over 3% to $3.87 billion. The Technology & Analytics Solutions unit saw a sales increase of more than 2%, while the R&D division experienced nearly 5% growth in sales. The Contract Sales & Medical Solutions business recorded a 2% increase in revenue. Looking ahead, IQVIA aims to achieve revenue of $15.4 billion to $15.65 billion by 2024, with its guidance including a $300 million impact from Covid-related sales.
Public Companies: IQVIA Holdings (IQV)
Private Companies:
Key People:
Factuality Level: 8
Justification: The article provides specific financial information about IQVIA Holdings’ fourth-quarter sales and profit, including earnings per share and revenue figures. It also mentions the growth across the company’s three divisions. The information is supported by data and includes analyst expectations. However, the article does not provide any additional context or analysis, which could have enhanced the overall factuality level.
Noise Level: 7
Justification: The article provides relevant information about IQVIA Holdings’ fourth-quarter sales and profit, as well as their revenue guidance for 2024. It includes data on the company’s earnings, adjusted earnings, and revenue, which is supported by analysts’ expectations. However, the article lacks in-depth analysis, antifragility considerations, and accountability of powerful people. It also does not provide actionable insights or solutions.
Financial Relevance: Yes
Financial Markets Impacted: IQVIA Holdings
Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article pertains to financial topics as it discusses IQVIA Holdings’ fourth-quarter sales and profit. There is no mention of an extreme event.
www.marketwatch.com 
